Cargando…
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study
OBJECTIVE: In this case-match study, we evaluated the impact of the CYP2C19*2 polymorphism in the occurrence of in-stent restenosis during a 1-year follow-up period despite adequate dual anti-platelet therapy in Iranian patients having undergone percutaneous coronary intervention (PCI). METHODS: Thi...
Autores principales: | Nozari, Younes, Vosooghi, Sirous, Boroumand, Mohammadali, Poorhosseini, Hamidreza, Nematipour, Ebrahim, Salarifar, Mojtaba, Kassaian, Seyed Ebrahim, Amirzadegan, Alireza, Alidoosti, Mohammad, Haji-Zeinali, Ali-Mohammad, Saroukhani, Sepideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779167/ https://www.ncbi.nlm.nih.gov/pubmed/25993709 http://dx.doi.org/10.5152/akd.2014.5418 |
Ejemplares similares
-
One-Year Clinical Outcomes of Ultra Long Apollo Polymer-Based Paclitaxel-Eluting Stents in Patients with Complex, Long Coronary Artery Lesions
por: Salarifar, Mojtaba, et al.
Publicado: (2011) -
Success Rate, Procedural Complications and Clinical Outcomes of Coronary Interventions in Octogenarians: a Case-Control Study
por: Poorhosseini, Hamidreza, et al.
Publicado: (2011) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013) -
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
por: Poorhosseini, Hamid Reza, et al.
Publicado: (2012) -
Effect of Early Treatment With Tirofiban on Initial TIMI Grade 3 Flow of Patients With ST Elevation Myocardial Infarction
por: Salarifar, Mojtaba, et al.
Publicado: (2014)